Does LEVOSIMENDAN Cause Left ventricular hypertrophy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Left ventricular hypertrophy have been filed in association with LEVOSIMENDAN. This represents 4.9% of all adverse event reports for LEVOSIMENDAN.
9
Reports of Left ventricular hypertrophy with LEVOSIMENDAN
4.9%
of all LEVOSIMENDAN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From LEVOSIMENDAN?
Of the 9 reports, 9 (100.0%) required hospitalization.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOSIMENDAN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOSIMENDAN Cause?
Drug ineffective (64)
Cardiac failure (37)
Hypotension (37)
Off label use (28)
Respiratory failure (27)
Constipation (16)
Hypothyroidism (16)
Ejection fraction decreased (15)
Jugular vein distension (14)
Pulmonary hypertension (13)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which LEVOSIMENDAN Alternatives Have Lower Left ventricular hypertrophy Risk?
LEVOSIMENDAN vs LEVOSULPIRIDE
LEVOSIMENDAN vs LEVOTHYROXINE
LEVOSIMENDAN vs LEVOTHYROXINE\LEVOTHYROXINE
LEVOSIMENDAN vs LEVOTHYROXINE\LIOTHYRONINE
LEVOSIMENDAN vs LEVOXYL